Key Takeaways
- • Carnelian Capital launching ₹1,500–2,000 crore maiden private equity fund targeting the underserved mid-market segment of profitable companies seeking ₹100–300 crore in growth capital, with fundraising expected to close within 12–18 months.
- • Fund structure includes ₹800 crore green-shoe option and will deploy capital across approximately 15–20 portfolio companies with a tenure of 6 years 9 months (extendable by up to 2 additional years), targeting Year 5 returns.
- • Market gap identified: Large domestic and global PE firms now focus on transactions of ₹1,000 crore or larger, while IPO market has shifted to ₹800–1,000 crore minimums, leaving profitable mid-sized businesses starved of accessible growth capital.
- • Vikas Khemani-led Carnelian Capital, which currently manages ₹18,300 crore across portfolio management services and alternative investment funds, is leveraging its boutique positioning to capture this institutional white space.
- • Investment strategy focuses on growth-stage and pre-IPO profitable companies with proven business models, explicitly avoiding early-stage venture investments and leveraged buyouts.
Summary
Carnelian Capital, the Mumbai-based investment manager founded by veteran market operator Vikas Khemani, is entering the private equity sector with a planned maiden fund capitalized at ₹1,500–2,000 crore. The firm intends to close fundraising within the next 12–18 months, marking a strategic expansion beyond its existing ₹18,300 crore asset base managed across portfolio management services and alternative investment funds.
The fund targets a distinct market inefficiency: the shortage of growth capital for mid-sized, profitable Indian companies. Specifically, Carnelian Capital will focus on businesses seeking ₹100–300 crore in growth financing—a segment that has become materially underserved as larger domestic and global private equity firms have increased their minimum ticket sizes to ₹1,000 crore or more. According to Khemani, this structural shift has created what the firm characterizes as "white space" in the market. Simultaneously, the IPO market has recalibrated toward larger offerings in the ₹800–1,000 crore range, effectively closing off a traditional exit pathway for mid-sized companies that previously used public markets for capital raises.
The fund's investment mandate excludes early-stage venture capital and leveraged buyouts, instead concentrating on growth-stage and pre-IPO companies with demonstrated profitability and established business models. The vehicle is structured as a Category II Alternative Investment Fund with an ₹800 crore green-shoe option embedded within the target corpus. The fund will maintain a tenure of 6 years 9 months from first close, with management retaining discretion to extend the vehicle by an additional two years. Carnelian Capital estimates the fund will deploy capital across approximately 15–20 portfolio companies, with internal performance targets calibrated to Year 5 returns.
This initiative reflects a broader shift in Indian private equity, where boutique managers are increasingly differentiated by their ability to serve market segments overlooked by mega-fund managers. Khemani's positioning of the fund as a solution to the underfinanced middle market—neither venture-scale nor mega-buyout scale—suggests Carnelian Capital is betting on sustained demand from profitable, growth-oriented companies in the ₹100–300 crore capital-raise band.
The fund targets a distinct market inefficiency: the shortage of growth capital for mid-sized, profitable Indian companies. Specifically, Carnelian Capital will focus on businesses seeking ₹100–300 crore in growth financing—a segment that has become materially underserved as larger domestic and global private equity firms have increased their minimum ticket sizes to ₹1,000 crore or more. According to Khemani, this structural shift has created what the firm characterizes as "white space" in the market. Simultaneously, the IPO market has recalibrated toward larger offerings in the ₹800–1,000 crore range, effectively closing off a traditional exit pathway for mid-sized companies that previously used public markets for capital raises.
The fund's investment mandate excludes early-stage venture capital and leveraged buyouts, instead concentrating on growth-stage and pre-IPO companies with demonstrated profitability and established business models. The vehicle is structured as a Category II Alternative Investment Fund with an ₹800 crore green-shoe option embedded within the target corpus. The fund will maintain a tenure of 6 years 9 months from first close, with management retaining discretion to extend the vehicle by an additional two years. Carnelian Capital estimates the fund will deploy capital across approximately 15–20 portfolio companies, with internal performance targets calibrated to Year 5 returns.
This initiative reflects a broader shift in Indian private equity, where boutique managers are increasingly differentiated by their ability to serve market segments overlooked by mega-fund managers. Khemani's positioning of the fund as a solution to the underfinanced middle market—neither venture-scale nor mega-buyout scale—suggests Carnelian Capital is betting on sustained demand from profitable, growth-oriented companies in the ₹100–300 crore capital-raise band.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.